Home › About us

About us

Pharmasite Research has offered clinical research studies in mental health since 1999, guided by a commitment to excellence in patient care and study conduct. Pharmasite is located in suburban Baltimore County, in Pikesville.

Pharmasite Research offers phase II, III and IV clinical trials evaluating treatments for disorders affecting children, adults and seniors. Our specialties include depression, anxiety disorders, insomnia, bipolar disorder, attention-deficit hyperactivity disorder, cognitive problems in dementia and behavioral problems associated with dementia.

Contact us by phone, email or by web-inquiry to see if you may qualify for a clinical study.

 

 Christine Coogan, Robin Boyle, Surya Korn, Toba Rudow, William Wright, Andra Waters, Dan Ressler, Dr. Robert B. Lehman, Dr. Alan Jonas.

Studies Seeking Volunteers

Geriatric Anxiety
PharmaSite Research is currently offering a clinical research study of a investigational medication for Generalized Anxiety Disorder in elderly patients.
Children and Adolescents with Anxiety
PharmaSite Research is currently offering a clinical research study for Generalized Anxiety Disorder in Children and Adolescents.
Bipolar Disorder / Manic Depression
PharmaSite Research is currently offering a clinical research study for depression associated with Bipolar 1 disorder.
Depression
PharmaSite Research is currently offering a clinical research study of a novel investigational medication for depression in adults. Major Depression is generally defined as experience of multiple symptoms of depression for at least 2 weeks.
Depression in Children and Adolescents
PharmaSite Research is currently offering a clinical research study of an investigational medication for depression in children and adolescents.
Treatment Resistant Depression
Treatment-resistant depression is generally defined as the continuation of depression symptoms despite treatment with at least one medication. This study evaluates the effectiveness and safety of an investigational medication or placebo added to an antidepressant.

More Studies...